Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gli3
|
ENSMUSG00000021318.9 | GLI-Kruppel family member GLI3 |
Zic1
|
ENSMUSG00000032368.8 | zinc finger protein of the cerebellum 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_15464892_15465326 | Gli3 | 1129 | 0.381460 | 0.74 | 7.6e-11 | Click! |
chr13_15462780_15463366 | Gli3 | 162 | 0.755259 | 0.68 | 1.3e-08 | Click! |
chr13_15468731_15468930 | Gli3 | 4850 | 0.198141 | 0.67 | 2.0e-08 | Click! |
chr13_15468239_15468390 | Gli3 | 4334 | 0.202788 | 0.65 | 7.0e-08 | Click! |
chr13_15464331_15464482 | Gli3 | 426 | 0.612374 | 0.63 | 2.0e-07 | Click! |
chr9_91366421_91366589 | Zic1 | 695 | 0.502892 | 0.53 | 3.2e-05 | Click! |
chr9_91365123_91365526 | Zic1 | 444 | 0.703103 | 0.51 | 7.5e-05 | Click! |
chr9_91364763_91365103 | Zic1 | 835 | 0.439144 | 0.49 | 1.4e-04 | Click! |
chr9_91365711_91366045 | Zic1 | 68 | 0.947493 | 0.44 | 7.7e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_50832696_50833456 | 122.66 |
Alg9 |
asparagine-linked glycosylation 9 (alpha 1,2 mannosyltransferase) |
2495 |
0.22 |
chr4_117095607_117096451 | 15.46 |
Ptch2 |
patched 2 |
46 |
0.94 |
chr1_85917187_85917621 | 14.56 |
4933407L21Rik |
RIKEN cDNA 4933407L21 gene |
11079 |
0.12 |
chr9_73103383_73103865 | 14.27 |
Khdc3 |
KH domain containing 3, subcortical maternal complex member |
1114 |
0.26 |
chr14_14350947_14351733 | 14.22 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr12_50967293_50967758 | 13.75 |
Gm40421 |
predicted gene, 40421 |
37348 |
0.16 |
chr15_82925083_82925236 | 12.62 |
Tcf20 |
transcription factor 20 |
13025 |
0.14 |
chr17_25570380_25571317 | 12.26 |
Cerox1 |
cytoplasmic endogenous regulator of oxidative phosphorylation 1 |
4 |
0.66 |
chr16_17927727_17929021 | 12.11 |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
155 |
0.9 |
chr9_124439906_124440949 | 12.10 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr1_80240139_80240290 | 12.08 |
2310015K22Rik |
RIKEN cDNA 2310015K22 gene |
15170 |
0.12 |
chr13_59927920_59928102 | 11.68 |
Gm48390 |
predicted gene, 48390 |
8573 |
0.16 |
chr3_80608550_80608733 | 11.51 |
Gm25749 |
predicted gene, 25749 |
83672 |
0.1 |
chr6_103512188_103512529 | 11.45 |
Chl1 |
cell adhesion molecule L1-like |
1028 |
0.51 |
chr14_60554058_60554987 | 11.44 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr13_60085093_60085249 | 11.30 |
Gm48397 |
predicted gene, 48397 |
16530 |
0.15 |
chr16_78101721_78102248 | 11.15 |
Gm5675 |
predicted gene 5675 |
15116 |
0.21 |
chr15_85708879_85709635 | 11.08 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr15_64579117_64579268 | 10.59 |
Gm30691 |
predicted gene, 30691 |
54316 |
0.16 |
chr6_14898190_14898764 | 10.51 |
Foxp2 |
forkhead box P2 |
2872 |
0.41 |
chr3_17787880_17788087 | 10.48 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1938 |
0.32 |
chr5_30920760_30922186 | 10.36 |
Khk |
ketohexokinase |
42 |
0.93 |
chr5_20068672_20068823 | 10.34 |
Gm23570 |
predicted gene, 23570 |
23868 |
0.22 |
chr7_50357328_50357516 | 10.33 |
Nell1os |
NEL-like 1, opposite strand |
216684 |
0.02 |
chr3_55352389_55352685 | 10.31 |
Dclk1 |
doublecortin-like kinase 1 |
1597 |
0.36 |
chr4_4138176_4138388 | 10.11 |
A830012C17Rik |
RIKEN cDNA A830012C17 gene |
39 |
0.71 |
chr4_110050502_110051534 | 9.97 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr16_44552002_44552354 | 9.54 |
Mir3081 |
microRNA 3081 |
5951 |
0.22 |
chr13_83744885_83745867 | 9.42 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
6513 |
0.13 |
chr10_38554173_38554374 | 9.32 |
Gm22911 |
predicted gene, 22911 |
61208 |
0.14 |
chr13_30782030_30782219 | 9.25 |
Gm29675 |
predicted gene, 29675 |
13102 |
0.19 |
chr8_10625329_10625480 | 9.21 |
5330413D20Rik |
RIKEN cDNA 5330413D20 gene |
51509 |
0.11 |
chr15_75968960_75969322 | 9.17 |
Zfp707 |
zinc finger protein 707 |
17 |
0.91 |
chr10_92438739_92438890 | 9.04 |
4930401A07Rik |
RIKEN cDNA 4930401A07 gene |
37800 |
0.13 |
chr11_117296657_117296938 | 9.04 |
Septin9 |
septin 9 |
11357 |
0.19 |
chr9_122571793_122572853 | 8.96 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr3_156559909_156560264 | 8.86 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
1496 |
0.36 |
chr2_109677143_109677796 | 8.85 |
Bdnf |
brain derived neurotrophic factor |
437 |
0.68 |
chr5_52593267_52593418 | 8.66 |
Gm5866 |
predicted gene 5866 |
11268 |
0.14 |
chr10_125912188_125912352 | 8.56 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
53898 |
0.17 |
chr14_55559782_55561003 | 8.54 |
A730061H03Rik |
RIKEN cDNA A730061H03 gene |
14 |
0.55 |
chr3_110011351_110011581 | 8.51 |
Gm12535 |
predicted gene 12535 |
104082 |
0.07 |
chr6_84105506_84106080 | 8.24 |
Dysf |
dysferlin |
420 |
0.76 |
chr4_117124515_117125246 | 8.18 |
Btbd19 |
BTB (POZ) domain containing 19 |
286 |
0.73 |
chr10_58233022_58233496 | 8.05 |
Duxf3 |
double homeobox family member 3 |
584 |
0.62 |
chr19_61225302_61226760 | 7.98 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr5_98166943_98167766 | 7.98 |
Prdm8 |
PR domain containing 8 |
156 |
0.95 |
chr13_63573352_63573844 | 7.97 |
Ptch1 |
patched 1 |
0 |
0.96 |
chr10_45009704_45010027 | 7.81 |
Gm4795 |
predicted pseudogene 4795 |
3755 |
0.21 |
chr12_107889880_107890128 | 7.80 |
Gm15208 |
predicted gene 15208 |
105963 |
0.07 |
chr13_63901198_63901761 | 7.76 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
7452 |
0.19 |
chr10_79681206_79682337 | 7.74 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr4_140070081_140070517 | 7.73 |
Gm13027 |
predicted gene 13027 |
61578 |
0.1 |
chr6_83794439_83795940 | 7.69 |
Nagk |
N-acetylglucosamine kinase |
19 |
0.94 |
chr5_99729383_99729870 | 7.67 |
Rasgef1b |
RasGEF domain family, member 1B |
561 |
0.73 |
chr8_44996642_44996793 | 7.59 |
Gm2366 |
predicted gene 2366 |
25668 |
0.16 |
chr3_55096333_55096615 | 7.58 |
Spg20 |
spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) |
15634 |
0.14 |
chr15_74156133_74156301 | 7.57 |
Gm15387 |
predicted gene 15387 |
61884 |
0.12 |
chr5_74999059_74999549 | 7.53 |
Gm42577 |
predicted gene 42577 |
10238 |
0.14 |
chr13_78182236_78182416 | 7.50 |
Gm38604 |
predicted gene, 38604 |
833 |
0.51 |
chr2_159431037_159431188 | 7.44 |
Gm14219 |
predicted gene 14219 |
25345 |
0.27 |
chr12_56614584_56614735 | 7.41 |
Nkx2-9 |
NK2 homeobox 9 |
1375 |
0.3 |
chr2_152114125_152114474 | 7.40 |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
8775 |
0.14 |
chr11_54057634_54057839 | 7.40 |
Pdlim4 |
PDZ and LIM domain 4 |
6832 |
0.16 |
chr3_114029993_114030781 | 7.38 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chr14_121713248_121713399 | 7.36 |
Dock9 |
dedicator of cytokinesis 9 |
14906 |
0.25 |
chr2_172888266_172888417 | 7.35 |
Gm22773 |
predicted gene, 22773 |
24000 |
0.18 |
chr10_36506466_36507103 | 7.30 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
30 |
0.99 |
chr13_24945670_24945856 | 7.15 |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
2611 |
0.19 |
chr2_104711782_104712014 | 7.11 |
Tcp11l1 |
t-complex 11 like 1 |
195 |
0.92 |
chr17_67764066_67764457 | 7.05 |
Lama1 |
laminin, alpha 1 |
48145 |
0.16 |
chr1_93176328_93177269 | 7.03 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
8073 |
0.13 |
chr4_114821500_114822451 | 7.03 |
Gm12830 |
predicted gene 12830 |
253 |
0.92 |
chr1_162225591_162226174 | 7.02 |
Mir214 |
microRNA 214 |
2514 |
0.24 |
chr6_72218349_72218558 | 6.95 |
Atoh8 |
atonal bHLH transcription factor 8 |
16084 |
0.15 |
chr18_25553907_25554097 | 6.90 |
Gm3227 |
predicted gene 3227 |
43488 |
0.17 |
chr9_106885145_106885733 | 6.90 |
Rbm15b |
RNA binding motif protein 15B |
180 |
0.9 |
chr13_117707111_117707262 | 6.90 |
4933413L06Rik |
RIKEN cDNA 4933413L06 gene |
12801 |
0.29 |
chr14_13284613_13284806 | 6.90 |
Gm5087 |
predicted gene 5087 |
71 |
0.5 |
chr14_77157704_77158027 | 6.86 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
1085 |
0.59 |
chr9_77339822_77340020 | 6.85 |
Mlip |
muscular LMNA-interacting protein |
706 |
0.65 |
chr1_75667800_75668013 | 6.84 |
Gm5257 |
predicted gene 5257 |
31516 |
0.15 |
chr2_33593309_33593623 | 6.82 |
Gm38011 |
predicted gene, 38011 |
20932 |
0.15 |
chr11_98959522_98960759 | 6.79 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr18_60862672_60862823 | 6.77 |
Tcof1 |
treacle ribosome biogenesis factor 1 |
13776 |
0.14 |
chr4_63459173_63459841 | 6.77 |
Whrn |
whirlin |
1795 |
0.32 |
chr7_57591534_57591735 | 6.74 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
104 |
0.97 |
chr13_54332427_54332695 | 6.74 |
Gm48622 |
predicted gene, 48622 |
4681 |
0.18 |
chr11_49901287_49901495 | 6.69 |
Rasgef1c |
RasGEF domain family, member 1C |
444 |
0.8 |
chr3_154548123_154548332 | 6.67 |
Tyw3 |
tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) |
46307 |
0.14 |
chr12_108037358_108037909 | 6.65 |
Bcl11b |
B cell leukemia/lymphoma 11B |
34031 |
0.2 |
chr2_157559818_157560258 | 6.61 |
Blcap |
bladder cancer associated protein |
31 |
0.5 |
chr13_37492599_37492825 | 6.61 |
Gm47732 |
predicted gene, 47732 |
10327 |
0.1 |
chr4_87768044_87768282 | 6.56 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
38131 |
0.21 |
chr3_121025658_121025888 | 6.51 |
Gm42926 |
predicted gene 42926 |
4009 |
0.24 |
chr7_89908523_89908738 | 6.50 |
Ccdc81 |
coiled-coil domain containing 81 |
5001 |
0.17 |
chr2_154421078_154421682 | 6.50 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr13_93966482_93966633 | 6.50 |
Gm24737 |
predicted gene, 24737 |
10247 |
0.18 |
chr6_65672100_65672953 | 6.50 |
Ndnf |
neuron-derived neurotrophic factor |
936 |
0.63 |
chr9_108460151_108461186 | 6.46 |
Ccdc71 |
coiled-coil domain containing 71 |
133 |
0.64 |
chr7_6926251_6926446 | 6.43 |
Usp29 |
ubiquitin specific peptidase 29 |
21254 |
0.11 |
chr2_130408363_130408514 | 6.42 |
Tmem239 |
transmembrane 239 |
1960 |
0.15 |
chr9_63092018_63092322 | 6.39 |
Gm48193 |
predicted gene, 48193 |
9197 |
0.17 |
chr8_3493298_3493991 | 6.38 |
Zfp358 |
zinc finger protein 358 |
474 |
0.67 |
chr8_127063794_127064607 | 6.38 |
Pard3 |
par-3 family cell polarity regulator |
45 |
0.97 |
chr18_50229223_50229380 | 6.35 |
AC118632.1 |
ATP synthase 6, mitochondria (mt-Atp6) pseudogene |
5337 |
0.17 |
chr2_146920755_146920906 | 6.35 |
Kiz |
kizuna centrosomal protein |
32053 |
0.19 |
chr10_106469332_106470360 | 6.28 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr2_109693106_109694421 | 6.27 |
Bdnf |
brain derived neurotrophic factor |
200 |
0.94 |
chr7_28049561_28049956 | 6.19 |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
290 |
0.84 |
chr2_147188117_147188295 | 6.18 |
6430503K07Rik |
RIKEN cDNA 6430503K07 gene |
782 |
0.52 |
chr14_79677458_79677610 | 6.15 |
Cnmd |
chondromodulin |
15364 |
0.14 |
chr8_48224421_48225088 | 6.10 |
Gm32842 |
predicted gene, 32842 |
46231 |
0.16 |
chr8_77815310_77815902 | 6.08 |
Gm23981 |
predicted gene, 23981 |
8071 |
0.24 |
chr13_99516425_99517155 | 6.07 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr8_12915219_12915955 | 6.07 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr10_120551981_120552172 | 6.06 |
Gm24298 |
predicted gene, 24298 |
53461 |
0.11 |
chr7_67910990_67911267 | 6.05 |
Gm44666 |
predicted gene 44666 |
24543 |
0.16 |
chr7_44351033_44351203 | 6.05 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
356 |
0.69 |
chr8_88544956_88545107 | 6.05 |
Gm45496 |
predicted gene 45496 |
15002 |
0.19 |
chr7_137316861_137317678 | 6.03 |
Ebf3 |
early B cell factor 3 |
2824 |
0.26 |
chr18_12643212_12644484 | 5.99 |
Ttc39c |
tetratricopeptide repeat domain 39C |
486 |
0.46 |
chr4_140030529_140030720 | 5.98 |
Klhdc7a |
kelch domain containing 7A |
62598 |
0.09 |
chr12_51101018_51101169 | 5.94 |
Gm22088 |
predicted gene, 22088 |
15406 |
0.21 |
chr5_24730535_24730920 | 5.93 |
Wdr86 |
WD repeat domain 86 |
0 |
0.97 |
chr6_21214448_21215029 | 5.88 |
Kcnd2 |
potassium voltage-gated channel, Shal-related family, member 2 |
765 |
0.74 |
chr9_106355974_106356661 | 5.87 |
Dusp7 |
dual specificity phosphatase 7 |
12315 |
0.12 |
chr13_77868459_77868617 | 5.87 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
156364 |
0.03 |
chr5_111631924_111632160 | 5.84 |
Gm42489 |
predicted gene 42489 |
38426 |
0.15 |
chr3_89315223_89316179 | 5.78 |
Gm15998 |
predicted gene 15998 |
262 |
0.77 |
chr15_74535818_74536181 | 5.72 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
4398 |
0.21 |
chr13_99151251_99151402 | 5.70 |
Zfp366 |
zinc finger protein 366 |
33497 |
0.15 |
chr3_104790339_104791400 | 5.69 |
Rhoc |
ras homolog family member C |
1114 |
0.3 |
chr8_84742133_84743295 | 5.69 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
19707 |
0.09 |
chr8_3499866_3501209 | 5.67 |
Mcoln1 |
mucolipin 1 |
3 |
0.96 |
chr8_88316500_88316952 | 5.65 |
Adcy7 |
adenylate cyclase 7 |
4469 |
0.22 |
chr3_94363621_94364486 | 5.65 |
C2cd4d |
C2 calcium-dependent domain containing 4D |
1550 |
0.16 |
chr4_68954543_68954884 | 5.64 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
316 |
0.95 |
chr4_32479359_32479510 | 5.64 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
22071 |
0.22 |
chr17_83238511_83238765 | 5.61 |
Pkdcc |
protein kinase domain containing, cytoplasmic |
17603 |
0.19 |
chrX_161997506_161998003 | 5.60 |
Gm26317 |
predicted gene, 26317 |
71703 |
0.11 |
chr16_90706305_90706649 | 5.59 |
Mis18a |
MIS18 kinetochore protein A |
20662 |
0.13 |
chr10_91241133_91241544 | 5.58 |
Gm47081 |
predicted gene, 47081 |
13152 |
0.15 |
chr7_19345577_19345798 | 5.54 |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
527 |
0.51 |
chr14_25064352_25064503 | 5.53 |
Gm38408 |
predicted gene, 38408 |
10017 |
0.16 |
chr6_6159596_6159747 | 5.51 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
14280 |
0.25 |
chr10_94458837_94458988 | 5.51 |
Gm16155 |
predicted gene 16155 |
50021 |
0.13 |
chr18_65521206_65521450 | 5.48 |
Gm30018 |
predicted gene, 30018 |
10473 |
0.12 |
chr18_35482718_35483270 | 5.47 |
Gm50145 |
predicted gene, 50145 |
6110 |
0.11 |
chr7_64509963_64510114 | 5.46 |
Gm45082 |
predicted gene 45082 |
5273 |
0.19 |
chr15_51628664_51628831 | 5.44 |
Gm34562 |
predicted gene, 34562 |
888 |
0.71 |
chr3_78810812_78811042 | 5.44 |
Gm18952 |
predicted gene, 18952 |
52308 |
0.13 |
chr7_69579254_69579507 | 5.43 |
Gm44535 |
predicted gene 44535 |
328 |
0.9 |
chrX_99482045_99482291 | 5.42 |
Pja1 |
praja ring finger ubiquitin ligase 1 |
10895 |
0.2 |
chr12_73039202_73039353 | 5.40 |
Six1 |
sine oculis-related homeobox 1 |
3538 |
0.25 |
chr6_77243554_77244106 | 5.40 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
908 |
0.69 |
chr19_47398126_47398317 | 5.39 |
Sh3pxd2a |
SH3 and PX domains 2A |
12138 |
0.21 |
chr10_80145825_80146996 | 5.37 |
Midn |
midnolin |
1862 |
0.15 |
chr2_124090269_124091058 | 5.35 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
694 |
0.78 |
chr9_114026283_114026988 | 5.35 |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
91 |
0.97 |
chr7_137723727_137724040 | 5.33 |
Gm45682 |
predicted gene 45682 |
10383 |
0.28 |
chr6_82917848_82918001 | 5.32 |
Sema4f |
sema domain, immunoglobulin domain (Ig), TM domain, and short cytoplasmic domain |
338 |
0.78 |
chr13_60737684_60738259 | 5.32 |
Dapk1 |
death associated protein kinase 1 |
16025 |
0.15 |
chr16_20589687_20589897 | 5.30 |
Vwa5b2 |
von Willebrand factor A domain containing 5B2 |
59 |
0.88 |
chr12_3364588_3366025 | 5.29 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr7_136209374_136209894 | 5.28 |
Gm36737 |
predicted gene, 36737 |
36338 |
0.17 |
chr3_110143512_110144184 | 5.27 |
Ntng1 |
netrin G1 |
163 |
0.97 |
chr15_95528183_95528844 | 5.27 |
Nell2 |
NEL-like 2 |
46 |
0.98 |
chr5_111761615_111761950 | 5.26 |
E130006D01Rik |
RIKEN cDNA E130006D01 gene |
57 |
0.97 |
chr18_37843820_37844130 | 5.24 |
Diaph1 |
diaphanous related formin 1 |
9432 |
0.07 |
chr1_81520769_81521201 | 5.23 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr7_139299500_139299682 | 5.23 |
Gm32486 |
predicted gene, 32486 |
2726 |
0.26 |
chr15_8632402_8632747 | 5.22 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
10673 |
0.2 |
chr4_97839916_97840102 | 5.19 |
Nfia |
nuclear factor I/A |
40110 |
0.18 |
chr8_55121794_55122373 | 5.19 |
Gm8734 |
predicted gene 8734 |
40368 |
0.14 |
chr9_41890642_41891131 | 5.17 |
Gm40513 |
predicted gene, 40513 |
282 |
0.9 |
chr2_171863445_171863658 | 5.14 |
1700028P15Rik |
RIKEN cDNA 1700028P15 gene |
98580 |
0.07 |
chr3_53207177_53207328 | 5.13 |
Lhfp |
lipoma HMGIC fusion partner |
22073 |
0.18 |
chr13_64003105_64003421 | 5.12 |
Gm7695 |
predicted gene 7695 |
56742 |
0.1 |
chr14_122367302_122367453 | 5.12 |
Gm25464 |
predicted gene, 25464 |
20783 |
0.17 |
chr13_24604767_24604999 | 5.11 |
Gm11346 |
predicted gene 11346 |
42 |
0.98 |
chr7_4471191_4471733 | 5.10 |
Gm15494 |
predicted gene 15494 |
177 |
0.87 |
chr2_25178392_25178552 | 5.08 |
Nrarp |
Notch-regulated ankyrin repeat protein |
2286 |
0.11 |
chr7_122478149_122478324 | 5.07 |
Gm14389 |
predicted gene 14389 |
6184 |
0.17 |
chr4_130865879_130866098 | 5.05 |
Gm22660 |
predicted gene, 22660 |
8108 |
0.15 |
chr4_62263509_62263676 | 5.05 |
Gm23148 |
predicted gene, 23148 |
722 |
0.49 |
chr1_22806069_22806442 | 5.04 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
261 |
0.95 |
chr3_85300229_85300586 | 5.04 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17112 |
0.24 |
chr15_85582000_85582250 | 5.03 |
Wnt7b |
wingless-type MMTV integration site family, member 7B |
304 |
0.8 |
chr1_106514242_106514393 | 5.01 |
D630008O14Rik |
RIKEN cDNA D630008O14 gene |
27626 |
0.17 |
chr12_26885906_26886093 | 5.01 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
51126 |
0.18 |
chr6_129533069_129533908 | 5.01 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr17_56510062_56510456 | 5.00 |
Znrf4 |
zinc and ring finger 4 |
2172 |
0.23 |
chr5_21115674_21115825 | 5.00 |
Gm22490 |
predicted gene, 22490 |
1452 |
0.3 |
chr18_63924766_63925000 | 4.99 |
Gm24384 |
predicted gene, 24384 |
15727 |
0.21 |
chr7_79504714_79505014 | 4.98 |
Mir9-3 |
microRNA 9-3 |
400 |
0.7 |
chr17_56715552_56715731 | 4.98 |
Vmac |
vimentin-type intermediate filament associated coiled-coil protein |
1336 |
0.25 |
chr5_125110808_125111013 | 4.94 |
Ncor2 |
nuclear receptor co-repressor 2 |
13990 |
0.18 |
chr2_50066246_50067049 | 4.93 |
Lypd6 |
LY6/PLAUR domain containing 6 |
183 |
0.97 |
chr11_108934993_108935378 | 4.93 |
Axin2 |
axin 2 |
3689 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 14.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
3.5 | 17.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
2.8 | 8.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.8 | 8.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.7 | 8.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.7 | 8.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.4 | 7.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.4 | 7.1 | GO:0033058 | directional locomotion(GO:0033058) |
2.3 | 6.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.2 | 6.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.2 | 25.9 | GO:0071625 | vocalization behavior(GO:0071625) |
2.0 | 8.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.9 | 5.7 | GO:0072197 | ureter morphogenesis(GO:0072197) |
1.9 | 5.6 | GO:0021564 | vagus nerve development(GO:0021564) |
1.8 | 3.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.8 | 5.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.8 | 5.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.8 | 10.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 5.3 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.7 | 5.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.7 | 6.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.6 | 8.2 | GO:0035989 | tendon development(GO:0035989) |
1.5 | 4.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 3.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.5 | 6.0 | GO:0003383 | apical constriction(GO:0003383) |
1.5 | 4.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.5 | 5.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.4 | 5.8 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.4 | 4.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.4 | 4.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.4 | 4.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.4 | 4.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
1.4 | 1.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.4 | 1.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.3 | 4.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.3 | 1.3 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.3 | 2.5 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.3 | 7.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 3.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 1.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.2 | 7.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.2 | 2.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 4.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
1.2 | 3.5 | GO:0015755 | fructose transport(GO:0015755) |
1.2 | 3.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.2 | 6.9 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
1.2 | 5.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.1 | 4.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.1 | 5.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.1 | 3.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.1 | 2.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.1 | 5.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.1 | 5.5 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
1.1 | 3.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 2.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.1 | 1.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.0 | 3.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 8.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.0 | 8.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 1.0 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.0 | 2.0 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
1.0 | 5.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.0 | 3.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
1.0 | 3.9 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.0 | 13.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.0 | 7.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.9 | 1.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.9 | 2.8 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.9 | 4.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.9 | 2.8 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.9 | 7.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.9 | 2.8 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.9 | 1.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.9 | 2.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 2.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 0.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 4.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.9 | 0.9 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.9 | 4.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.9 | 1.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 0.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.9 | 2.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.9 | 0.9 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.8 | 1.7 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 2.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.8 | 2.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 5.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 4.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.8 | 2.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.8 | 1.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.8 | 2.4 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 4.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.8 | 2.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.8 | 2.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.8 | 4.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.8 | 3.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 4.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.8 | 2.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.8 | 7.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 2.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 0.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.8 | 2.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.8 | 0.8 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.8 | 0.8 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 2.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.8 | 3.1 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 2.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.8 | 2.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 1.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.7 | 2.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 2.2 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.7 | 4.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 3.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.7 | 3.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.7 | 2.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 2.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.7 | 2.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.7 | 1.5 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 1.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.7 | 10.1 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.7 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.7 | 1.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.7 | 2.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 4.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.7 | 0.7 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.7 | 2.8 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.7 | 0.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.7 | 1.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 2.0 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.7 | 2.7 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.7 | 2.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.7 | 3.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.7 | 2.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 6.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.6 | 1.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.6 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 4.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 0.6 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.6 | 1.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.6 | 2.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.6 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.6 | 3.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 2.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 3.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.6 | 4.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.6 | 3.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.6 | 0.6 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.6 | 1.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.6 | 2.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.6 | 7.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 1.8 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.6 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 3.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.6 | 1.8 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 2.4 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.6 | 1.8 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.6 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.6 | 1.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 1.7 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 2.3 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 7.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 2.2 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.6 | 3.9 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 3.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 1.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 1.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 1.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.5 | 2.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 1.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 1.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 1.1 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.5 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 5.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 4.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 2.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 0.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 1.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.5 | 0.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 15.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.5 | 1.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 5.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.5 | 3.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 2.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.5 | 1.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 3.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 2.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.5 | 1.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 1.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.5 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 1.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.5 | 1.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.5 | 1.5 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 2.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 8.3 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 1.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 2.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 4.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.5 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.5 | 3.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 8.9 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.5 | 3.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.5 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.5 | 1.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 3.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 5.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 2.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.4 | 0.4 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.4 | 2.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 4.8 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.4 | 0.9 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 1.7 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 7.9 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.4 | 1.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 4.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 35.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.4 | 1.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 3.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.9 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 1.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.4 | 1.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.4 | 0.4 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.4 | 1.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.4 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.4 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 19.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 2.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 1.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 0.8 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.4 | 0.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 0.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 0.8 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.4 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 2.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 2.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 0.8 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.4 | 2.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 4.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.4 | 1.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 3.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 1.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.8 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 2.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 5.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.4 | 0.8 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.4 | 1.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 1.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.9 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 6.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 1.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.4 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.4 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 2.5 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 2.5 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 0.4 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 2.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.4 | 2.8 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.4 | 1.8 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.4 | 1.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 2.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 2.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.3 | 1.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 2.0 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 1.0 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 0.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.3 | 0.6 | GO:0060290 | transdifferentiation(GO:0060290) |
0.3 | 0.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 0.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 1.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.3 | 0.3 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 0.3 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.3 | 1.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 3.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.9 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.3 | GO:1903421 | positive regulation of synaptic vesicle transport(GO:1902805) regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 1.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.3 | 0.9 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.6 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 5.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.3 | 0.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.3 | 0.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 0.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 0.9 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.3 | 0.6 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 1.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 1.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.3 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 0.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 2.9 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 2.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 3.1 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 1.5 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus development(GO:0060482) |
0.3 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.8 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
0.3 | 2.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 1.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) regulation of cardiac muscle cell membrane repolarization(GO:0099623) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 0.2 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 1.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.2 | 0.2 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 4.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 3.6 | GO:0032835 | glomerulus development(GO:0032835) |
0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 4.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 0.2 | GO:0031946 | negative regulation of glucocorticoid metabolic process(GO:0031944) regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.2 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 3.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.1 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.2 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.2 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 2.0 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.2 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.2 | 0.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 0.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 0.7 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.2 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.2 | 0.9 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 1.7 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 0.6 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.2 | 0.8 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 4.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 1.5 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.2 | 1.6 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.2 | 0.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 1.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.2 | 1.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 0.2 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.2 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 0.8 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.2 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.2 | 1.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 3.4 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.9 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 4.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.2 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 1.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 0.7 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.2 | GO:0072234 | metanephric nephron tubule development(GO:0072234) |
0.2 | 2.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 1.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.9 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.2 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.7 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 1.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 1.4 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.2 | 0.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 0.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.2 | 0.8 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.2 | 0.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 1.6 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.2 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 0.2 | GO:1901626 | regulation of postsynaptic membrane organization(GO:1901626) |
0.2 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 5.8 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.2 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 3.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 0.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.2 | 2.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.6 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.2 | 0.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 2.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 1.0 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.6 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 1.7 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.0 | GO:0071436 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
0.1 | 0.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.3 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 2.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.4 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.1 | 1.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.4 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.3 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 1.0 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.5 | GO:0001975 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.1 | 0.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.1 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 3.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.9 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 5.4 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 3.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 0.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.2 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.8 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 0.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.3 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.5 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.2 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.1 | 0.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 1.4 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.1 | 0.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.8 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.7 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.1 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 1.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 0.1 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.1 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.3 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.8 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:2000542 | negative regulation of endodermal cell differentiation(GO:1903225) negative regulation of gastrulation(GO:2000542) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.5 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.1 | 0.2 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0032824 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.1 | 1.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 3.3 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 1.4 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.4 | GO:0050802 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.5 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.0 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.3 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.8 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.2 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.1 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 1.0 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.0 | 0.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.0 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.2 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.3 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.1 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.1 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.0 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.0 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.0 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.2 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.0 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.0 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.0 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.0 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 | 0.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.0 | 0.0 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:1990635 | proximal dendrite(GO:1990635) |
1.9 | 5.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
1.6 | 4.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.5 | 18.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.5 | 1.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.5 | 10.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.4 | 5.5 | GO:0033269 | internode region of axon(GO:0033269) |
1.3 | 4.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.2 | 14.9 | GO:0043194 | axon initial segment(GO:0043194) |
1.1 | 3.3 | GO:0032280 | symmetric synapse(GO:0032280) |
1.1 | 3.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 4.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 2.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 8.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 3.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 2.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.8 | 2.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 1.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.8 | 9.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 0.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.8 | 9.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 4.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 19.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 5.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.6 | 2.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.6 | 8.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 5.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 3.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 1.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 4.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.6 | 1.8 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 19.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 1.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 2.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 3.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 0.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.5 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 2.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 12.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 2.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.5 | 4.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 0.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 1.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.4 | 1.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 4.2 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 4.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 3.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 1.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 1.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 15.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 2.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 17.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 4.3 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 4.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 3.4 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 5.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 0.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 25.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 1.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.3 | 5.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 34.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 18.6 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 17.7 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 6.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 39.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 0.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 0.8 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.6 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 1.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 1.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 0.6 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.7 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 6.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 4.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 8.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 12.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 1.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 3.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 5.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.3 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 3.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 2.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 5.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 23.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 1.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 16.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.5 | 7.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.3 | 6.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.2 | 29.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.1 | 16.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.9 | 9.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.9 | 5.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.8 | 1.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.6 | 7.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.6 | 3.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.5 | 4.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.5 | 8.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.4 | 7.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.3 | 6.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.2 | 3.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 4.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.1 | 5.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 3.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 28.3 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.0 | 4.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.0 | 1.0 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.9 | 6.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.9 | 1.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.9 | 3.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 4.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.9 | 4.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.8 | 2.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 2.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 5.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.8 | 2.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.8 | 3.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 4.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 2.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.8 | 3.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 2.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 5.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 2.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.7 | 2.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 2.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 2.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 3.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.7 | 2.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 2.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.6 | 2.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.6 | 2.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 7.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 4.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.6 | 2.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 1.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.6 | 33.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 3.9 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 6.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 18.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.5 | 1.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.5 | 6.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.5 | 10.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 2.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 3.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 2.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 5.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 7.3 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.5 | 1.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 14.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 0.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.5 | 6.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 4.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.5 | 11.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 2.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.4 | 2.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 2.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 1.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.4 | 10.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 0.4 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.4 | 2.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 3.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 6.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 0.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 2.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 3.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 3.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.4 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 17.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 1.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 0.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 2.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 3.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 2.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 5.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 3.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 0.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 0.6 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 1.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 35.3 | GO:0008201 | heparin binding(GO:0008201) |
0.3 | 1.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.3 | 0.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 7.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.3 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 5.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 6.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 2.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 2.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 9.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 0.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.0 | GO:0038100 | nodal binding(GO:0038100) |
0.3 | 3.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 2.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 3.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 12.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 4.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 2.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 4.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 1.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 5.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 8.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 2.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.4 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 1.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 2.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.2 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 4.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 1.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 1.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 5.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 2.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.5 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.9 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.2 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.5 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.2 | 0.3 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.2 | 2.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 0.3 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 1.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.5 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 0.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 3.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 1.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 2.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 0.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 2.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 3.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 3.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 1.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 2.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 2.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 1.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.3 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 2.0 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.1 | 0.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.3 | GO:0052622 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 4.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.9 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 1.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 1.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 1.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 2.0 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.6 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.1 | 0.6 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 2.8 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.7 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 2.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 1.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 2.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.8 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.2 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.8 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 2.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 1.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.5 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.5 | GO:0017095 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 2.0 | GO:0001653 | peptide receptor activity(GO:0001653) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 1.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 2.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 2.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 9.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 2.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.2 | 2.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.0 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.0 | 21.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.0 | 1.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 9.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 25.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 2.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 9.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 2.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.4 | 12.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 5.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 12.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 2.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 11.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 6.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 12.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 5.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 38.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 4.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 3.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 38.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 3.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 16.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 4.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 12.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.0 | 3.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.8 | 7.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.7 | 2.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.7 | 11.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 17.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.7 | 5.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 7.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 0.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 8.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 25.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 30.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 6.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.5 | 6.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 11.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 1.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 4.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.5 | 5.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.5 | 38.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 16.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 10.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 2.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 4.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 6.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 2.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 6.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 3.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 1.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 1.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.3 | 10.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 1.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 12.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 3.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.3 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 2.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 3.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 5.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 5.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 2.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.8 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 3.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 2.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 3.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.2 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 3.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 3.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.5 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 11.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 3.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.0 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |